Trimazosin

Drug Profile

Trimazosin

Alternative Names: Cardovar; CP 191061; CP 23445; Supres; Trimazosin hydrochloride

Latest Information Update: 12 Jul 1996

Price : $50

At a glance

  • Originator Pfizer
  • Developer Bristol-Myers Squibb
  • Class Antihypertensives; Piperazines
  • Mechanism of Action Alpha adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Hypertension

Most Recent Events

  • 12 Jul 1996 A study has been added to the pharmacokinetics section
  • 31 Dec 1985 Launched for hypertension in Germany
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top